ORAMED PHARMACEUTICALS INC. (ORMP) › Operating IncomeORAMED PHARMACEUTICALS INC. (ORMP) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$2.44M2012: -$2.88M2013: $4.30M2014: -$5.91M2015: -$7.38M2016: -$10.01M2017: -$10.77M2018: -$13.53M2019: -$14.63M2020: -$11.76M2021: -$24.22M2022: -$40.60M2023: -$15.77M2024: -$12.78M2025: -$15.09M-$15.09M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$15.09M-18.1%2024-$12.78M+18.9%2023-$15.77M+61.2%2022-$40.60M-67.6%2021-$24.22M-106.0%2020-$11.76M+19.6%2019-$14.63M-8.2%2018-$13.53M-25.6%2017-$10.77M-7.6%2016-$10.01M-35.6%2015-$7.38M-25.0%2014-$5.91M-237.2%2013$4.30M+249.2%2012-$2.88M-18.4%2011-$2.44M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share